English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
Spanish Lung Cancer Group
Share :
ESMO 33
12 - 16 Sep 2008
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Dec 2008
Views:
16588
Rating:
Save
Rate video
Prof. Rafael Rosel
Benefits of customising erlotinib therapy for NSCLC.
Categories:
Lung & pleura
Related Videos
ASCO 2024: Lung cancer highlights
Dr Antonio Passaro, Dr Matthew Krebs, Prof Raffaele Califano, Prof Nicolas...
26 Jun 2024
ASCO 2024: Lung cancer roundup
Dr Luis Raez - Memorial Cancer Institute, Miami, USA
4 Jun 2024
ASCO 2024: Advances in NSCLC
Dr Enriqueta Felip, Dr Alex Spira, Dr Antonio Passaro and Dr Alfredo Addeo
3 Jun 2024
Durvalumab after chemoradiotherapy improves survival in limited-stage SCLC
Dr David Spigel - Sarah Cannon Research Institute, Nashville, USA
3 Jun 2024
Osimertinib success in locally advanced EGFR-mutated NSCLC
Dr Suresh Ramalingam - Emory University School of Medicine, Atlanta, USA
3 Jun 2024
Adagrasib improves on docetaxel in previously treated NSCLC
Dr Robert Jotte - Rocky Mountain Cancer Centers, Colorado
3 Jun 2024
Maintenance systemic therapy versus local consolidative therapy plus...
Dr Puneeth Iyengar - Memorial Sloan Kettering Cancer Center, New York, USA
3 Jun 2024
Telehealth delivery of palliative care an effective alternative to in-person...
Dr Joseph Greer - Harvard Medical School, Boston, USA
2 Jun 2024
Ivonescimab benefit for EGFR mutant NSCLC patients who failed TKI therapy
Prof Li Zhang - Sun Yat-Sen University Cancer Center, Guangzhou, China
1 Jun 2024
More from
e
cancer